Dabla V. Hitting the bull’s eye of ending tuberculosis goal: The challenge of addressing tuberculosis in human immunodeficiency virus positive population in India. World J Virol 2019; 8(1): 1-3 [PMID: 31911895 DOI: 10.5501/wjv.v8.i1.1]
Corresponding Author of This Article
Vandana Dabla, PhD, Senior Researcher, National Initiative to Strengthen and Coordinate HIV/TB Response in India, Society for Health Allied Research and Education India, Barakhamba Road, New Delhi 110001, India. vandana.dabla@gmail.com
Research Domain of This Article
Virology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Virol. Dec 31, 2019; 8(1): 1-3 Published online Dec 31, 2019. doi: 10.5501/wjv.v8.i1.1
Hitting the bull’s eye of ending tuberculosis goal: The challenge of addressing tuberculosis in human immunodeficiency virus positive population in India
Vandana Dabla
Vandana Dabla, National Initiative to Strengthen and Coordinate HIV/TB Response in India, Society for Health Allied Research and Education India, New Delhi 110001, India
Author contributions: Dabla V designed, performed research, analysed data and wrote the paper.
Conflict-of-interest statement: The author has no conflicts of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Vandana Dabla, PhD, Senior Researcher, National Initiative to Strengthen and Coordinate HIV/TB Response in India, Society for Health Allied Research and Education India, Barakhamba Road, New Delhi 110001, India. vandana.dabla@gmail.com
Received: September 26, 2019 Peer-review started: September 26, 2019 First decision: October 13, 2019 Revised: November 27, 2019 Accepted: December 14, 2019 Article in press: December 14, 2019 Published online: December 31, 2019
Abstract
Eradicating tuberculosis in human immunodeficiency virus is all the more important to realise India’s ambitious goal of tuberculosis free India by 2025. Although, continuous efforts are being made to address tuberculosis in human immunodeficiency virus co-infection, it is imperative to closely monitor the implemented strategies, encourage and validate disease notification system in the country, and bring about societal change to view this disease as an ailment only and not as a stigma.
Core tip: Addressing tuberculosis in human immunodeficiency virus (HIV-TB) is essential to achieve the goal of eradicating tuberculosis, as well as achieving the human immunodeficiency virus programme goal of zero mortality due to co-infection. Although, continuous efforts are being made to address HIV-TB co-infection, it is imperative to closely monitor the implemented strategies, encourage and validate disease notification, and document steps taken towards prevention and treatment under the HIV-TB umbrella in the country to realize its vision of sustainable health and eradicate it for good.
